The estimated Net Worth of Payman Khales is at least $3.38 Milione dollars as of 10 May 2024. Mr. Khales owns over 8,712 units of Integer Corp stock worth over $1,296,052 and over the last 7 years he sold ITGR stock worth over $991,774. In addition, he makes $1,091,560 as President - Cardio and Vascular at Integer Corp.
Sign up
Mr. Khales ITGR stock SEC Form 4 insiders trading
Payman has made over 8 trades of the Integer Corp stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 8,712 units of ITGR stock worth $991,774 on 10 May 2024.
The largest trade he's ever made was selling 8,712 units of Integer Corp stock on 10 May 2024 worth over $991,774. On average, Payman trades about 1,166 units every 93 days since 2018. As of 10 May 2024 he still owns at least 10,431 units of Integer Corp stock.
You can see the complete history of Mr. Khales stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Payman Khales biography
Payman Khales serves as President - Cardio and Vascular of the Company. Mr. Khales is also the leader for the Integer Market Focused Innovation strategic imperative. Prior to joining Integer, Mr. Khales was the President of the Environmental Technologies Segment at CECO Environmental Company from May 2014 through July 2017. Previously, he was employed by Ingersoll Rand Company where he held a variety of different roles in the United States and Canada, including Vice President Product Management for the global Power Tools division from January 2012 through April 2014, and Vice President Strategic Accounts & Channels from February 2010 through December 2011.
What is the salary of Payman Khales?
As the President - Cardio and Vascular of Integer Corp, the total compensation of Payman Khales at Integer Corp is $1,091,560. There are 4 executives at Integer Corp getting paid more, with Joseph Dziedzic having the highest compensation of $5,744,890.
How old is Payman Khales?
Payman Khales is 49, he's been the President - Cardio and Vascular of Integer Corp since 2018. There are 22 older and 2 younger executives at Integer Corp. The oldest executive at Integer Holdings Corp is Bill Sanford, 76, who is the Independent Chairman of the Board.
Insiders trading at Integer Corp
Over the last 8 years, insiders at Integer Corp have traded over $11,995,808 worth of Integer Corp stock and bought 28,350 units worth $1,274,625 . The most active insiders traders include Thomas J Hook, Filippo Passerini e Martin C Maxwell. On average, Integer Corp executives and independent directors trade stock every 14 days with the average trade being worth of $717,544. The most recent stock trade was executed by Diron Smith on 1 September 2024, trading 168 units of ITGR stock currently worth $20,874.
What does Integer Corp do?
integer holdings corporation (nyse:itgr) is a leader in advanced medical device outsourcing (mdo) and serves its customers by providing comprehensive end-to-end solutions with its unparalleled expertise in innovation and manufacturing. integer's vision is to enhance the lives of patients worldwide by being its customer's partner of choice for innovative medical technologies and services. additionally, through electrochem, an integer company, it develops custom batteries for high-end niche applications in energy, military, and environment markets. the company's medical device manufacturing brands include greatbatch™ medical and lake region medical™. additional information is available at www.integer.net.
What does Integer Corp's logo look like?
Complete history of Mr. Khales stock trades at Integer Corp
Integer Corp executives and stock owners
Integer Corp executives and other stock owners filed with the SEC include:
-
Joseph Dziedzic,
President, Chief Executive Officer, Director -
Joseph W. Dziedzic,
Pres, CEO & Director -
Jason Garland,
Chief Financial Officer, Executive Vice President -
Kirk Thor,
Chief Human Resource Officer, Executive Vice President -
Payman Khales,
President - Cardio and Vascular -
Jennifer Bolt,
Senior Vice President - Global Operations -
Joseph Flanagan,
Executive Vice President - Quality and Regulatory Affairs -
Jason K. Garland,
Exec. VP & CFO -
Payman Khales,
Pres of Cardio & Vascular -
Jennifer M. Bolt,
Sr. VP of Global Operations & ESG -
Joel D. Becker,
Pres of Cardiac Rhythm Management & Neuromodulation -
Bill Sanford,
Independent Chairman of the Board -
Jean Hobby,
Independent Director -
Martin Maxwell,
Independent Director -
Pamela Bailey,
Independent Director -
James Hinrichs,
Independent Director -
William Summers,
Independent Director -
Donald Spence,
Independent Director -
Filippo Passerini,
Independent Director -
Anthony Borowicz,
Senior Vice President, Strategy, Corporate Development -
Joel Becker,
President, CRM & Neuromodulation -
Margaret Carthy,
Sr. VP of Quality and Regulatory Affairs -
Kirk K. Thor,
Exec. VP & Chief HR Officer -
McAlister C. Marshall II,
Sr. VP, Gen. Counsel, Chief Ethics & Compliance Officer and Corp. Sec. -
Elizabeth K. Giddens,
Sr. VP, Gen. Counsel, Chief Ethics & Compliance Officer and Corp. Sec. -
Carter Houghton,
Pres of Portable Medical & Electrochem -
Margaret Carthy,
EVP, Qlty & Regulatory Affairs -
Jeremy Friedman,
EVP, COO -
Gary J Haire,
EVP & Chief Financial Officer -
Thomas J Hook,
President & CEO -
Declan Smyth,
Pres., Advanced Surgical, Orth -
Jose Antonio Gonzalez,
President, CRM & Neuro -
Peter H Soderberg,
Director -
Kristin Trecker,
Chief Human Resource Officer -
Timothy G Mc Evoy,
Sr. VP, Gen. Counsel & Sec. -
Thomas J Mazza,
VP, Corporate Controller -
John A Harris,
EVP, Global Ops and Manufactur -
Michael L Spencer,
Chief Ethics & Compliance Of -
Tommy P Thomas,
VP, Corporate Controller -
Diron Smith,
EVP, Chief Financial Officer -
Carter Houghton,
President, Electrochem -
Elizabeth Giddens,
SVP, General Counsel -
Jim Stephens,
President, CRM & Neuro -
Alvin Tyrone Jeffers,
Director -
Sheila Antrum,
Director -
Cheryl C Capps,
Director -
Mc Alister C Ii Marshall,
SVP, Gen Counsel & Secretary -
Andrew Senn,
SVP, Strategy and Business Dev